Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Company News
Events
Directory
Search
Close search
Home
Company
Epistem
Epistem
Activities:
Research & Development
X
LinkedIn
Trending Articles
Catalent and AstraZeneca to expand support for COVID-19 vaccine AZD1222
Catalent will prepare the Harmans facility, close to Baltimore-Washington International (BWI) airport, to enable multiple production trains to run in parallel to produce the...
How advanced technologies are unlocking the future of drug manufacturing
As the drug production landscape changes, it opens the door to pursue hybrid opportunities that push the boundaries of technological advancement in the field, reports Jon...
Andelyn Biosciences and Grace Science, LLC partner to manufacture AAV gene therapy
The partnership will seek to maximise programme efficiency, support the ongoing clinical trial and accelerate this critical therapy to patients
Teva UK and Closed Loop Medicine partner to advance personalised medicine development
SaMD platform aims to advance personalised medicine development, improve drug efficacy and patient outcomes with specific chronic conditions
Henkel facilities receive EXCiPACT certificate as suppliers of pharmaceutical excipients
The certification means Henkel meets EXCiPACT’s guidelines for good manufacturing practice (GMP) and good distribution practice (GDP)
Upcoming event
BioProcess International Europe
9-12 April 2024 | Exhibition | RAI Amsterdam
See all
Related Content
Pharmaceutical
David Budd to join Epistem as Chief Executive
He will start his new role by the middle of April
Research & Development
Epistem opens US laboratory in Baltimore
Currently offers histology and immunohistochemistry (IHC) services
Research & Development
UK-Norwegian team to develop living skin equivalent testing model
For testing inflammatory responses
Research & Development
Epistem announces three-year collaboration with GSK
Will apply RND-Amp technology to fibrosis research
Research & Development
Epistem signs three-year research deal with sanofi-aventis
Will provide discovery through to clinical biomarker support to sanofi-aventis oncology programmes
Research & Development
Epistem awarded US$3.5m in NIH biodefence contract
Consortium is developing drugs to treat radiation damage to the gastrointestinal tract
Manufacturing
Veritas becomes exclusive distributor in Japan for Epistem
Will enable Epistem to extend its research services in the region
Subscribe now